Bank of Montreal
SGMO

Bank of Montreal’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Bank of Montreal’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,000
Closed -$12.2K – 3715
2024
Q4 		$12.2K Sell
12,000
-57
-0.5% -$104 ﹤0.01% 3318
2024
Q3 		$10.5K Buy
+12,057
New +$8.83K ﹤0.01% 3656
2023
Q3 		– Sell
-10,919
Closed -$14.3K – 4188
2023
Q2 		$14.3K Sell
10,919
-5,605
-34% -$7.66K ﹤0.01% 3771
2023
Q1 		$34.5K Buy
16,524
+2,001
+14% +$5.71K ﹤0.01% 3431
2022
Q4 		$50.7K Buy
14,523
+2,371
+20% +$9.2K ﹤0.01% 3538
2022
Q3 		$64 Buy
12,152
+672
+6% +$3.45K ﹤0.01% 3568
2022
Q2 		$46 Buy
11,480
+796
+7% +$3.44K ﹤0.01% 3651
2022
Q1 		$63K Sell
10,684
-2,000
-16% -$11.9K ﹤0.01% 3751
2021
Q4 		$99K Sell
12,684
-165,669
-93% -$1.44M ﹤0.01% 3125
2021
Q3 		$1.7M Sell
178,353
-109,954
-38% -$1.09M ﹤0.01% 2163
2021
Q2 		$3.38M Buy
288,307
+15,552
+6% +$176K ﹤0.01% 1796
2021
Q1 		$3.07M Buy
272,755
+25,408
+10% +$342K ﹤0.01% 1578
2020
Q4 		$4.01M Sell
247,347
-47,122
-16% -$552K ﹤0.01% 1509
2020
Q3 		$2.85M Buy
294,469
+280,211
+1,965% +$3.03M ﹤0.01% 1503
2020
Q2 		$155K Buy
14,258
+11,969
+523% +$111K ﹤0.01% 2864
2020
Q1 		$16K Sell
2,289
-14,413
-86% -$107K ﹤0.01% 3333
2019
Q4 		$139K Sell
16,702
-9,179
-35% -$84.4K ﹤0.01% 3352
2019
Q3 		$234K Buy
25,881
+14,068
+119% +$158K ﹤0.01% 2818
2019
Q2 		$128K Buy
11,813
+9,618
+438% +$102K ﹤0.01% 3193
2019
Q1 		$21K Sell
2,195
-1,432
-39% -$14.6K ﹤0.01% 3662
2018
Q4 		$41K Sell
3,627
-344
-9% -$4.27K ﹤0.01% 3360
2018
Q3 		$66K Sell
3,971
-20
-0.5% -$304 ﹤0.01% 3274
2018
Q2 		$56K Sell
3,991
-49,647
-93% -$825K ﹤0.01% 3370
2018
Q1 		$1.02M Buy
53,638
+43,959
+454% +$940K ﹤0.01% 1910
2017
Q4 		$159K Buy
9,679
+1,578
+19% +$23.5K ﹤0.01% 2781
2017
Q3 		$122K Buy
8,101
+5,596
+223% +$61.9K ﹤0.01% 2906
2017
Q2 		$22K Buy
2,505
+2,195
+708% +$14.1K ﹤0.01% 3512
2017
Q1 		$2K Hold
310
– – ﹤0.01% 3839
2016
Q4 		$1K Hold
310
– – ﹤0.01% 3978
2016
Q3 		$1K Hold
310
– – ﹤0.01% 3945
2016
Q2 		$2K Hold
310
– – ﹤0.01% 3905
2016
Q1 		$2K Sell
310
-353
-53% -$2.12K ﹤0.01% 3983
2015
Q4 		$6K Buy
+663
New +$5.11K ﹤0.01% 3750
2015
Q3 		– Sell
-50,117
Closed -$556K – 4131
2015
Q2 		$556K Sell
50,117
-9,028
-15% -$116K ﹤0.01% 1915
2015
Q1 		$928K Buy
59,145
+13,097
+28% +$203K ﹤0.01% 1668
2014
Q4 		$701K Sell
46,048
-4,532
-9% -$55K ﹤0.01% 1888
2014
Q3 		$545K Sell
50,580
-10,120
-17% -$132K ﹤0.01% 2042
2014
Q2 		$927K Buy
60,700
+17,360
+40% +$250K ﹤0.01% 1785
2014
Q1 		$784K Buy
+43,340
New +$835K ﹤0.01% 1797

Other funds holding SGMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of Montreal's SGMO Position: Q1 2025 in Review

Bank of Montreal sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2025, closing a stake of 12,000 shares — an estimated $12.2K sold.

Bank of Montreal first reported a position in SGMO in Q1 2014 and held it in 39 quarters. The position peaked at $4.01M in Q4 2020. 122 funds tracked by Wall St. Rank hold SGMO as of Q1 2025.

  • Bank of Montreal reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2025 after selling out during the quarter.
  • Bank of Montreal sold 12,000 SANGAMO THERAPEUTICS INC shares in Q1 2025, an estimated $12.2K.
  • Bank of Montreal first reported a position in SANGAMO THERAPEUTICS INC in Q1 2014 and held it in 39 quarters.
  • Bank of Montreal's SANGAMO THERAPEUTICS INC position peaked at $4.01M in Q4 2020.
  • 122 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2025.

Based on Bank of Montreal's 13F filing for Q1 2025, filed 13 May 2025.